TORONTO – Health Canada has authorized brand name changes for three COVID-19 vaccines approved for use.
Health Canada said in a tweet on Thursday that the Pfizer-BioNtech vaccine will now be named Comirnati, the modern vaccine will be named SpikeVax and the AstraZeneca vaccine will be named VaxZeveria.
“These are just name changes. There has been no change in the vaccines themselves,” the agency tweeted.
The new vaccine names are already being used for promotional purposes in the European Union and the United States.
“While the vaccine brand name will be COMIRNATY following this approval, Canada will continue to receive vials of the vaccine labeled as Pfizer-BioNTech COVID-19 Vaccine,” Pfizer said in a news release on Thursday.
“The formulation for the Pfizer-BioNtech COVID-19 Vaccine is the same formulation as COMIRNATY and they are considered interchangeable by Health Canada to provide the COVID-19 vaccination series. In view of the ongoing pandemic, a gradual change to new labeling with the COMIRNATY brand name will take place at a later date.”
In a separate release, Moderna said it is pleased that the Spikevax vaccine has been approved by Health Canada.
With files from the Canadian Press